Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

P Strati, S Ahmed, F Furqan, LE Fayad… - Blood, The Journal …, 2021 - ashpublications.org
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.

P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee, SP Iyer… - Blood, 2021 - europepmc.org
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

P Strati, S Ahmed, F Furqan, LE Fayad… - …, 2021 - mdanderson.elsevierpure.com
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …

[HTML][HTML] Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee, SP Iyer… - Blood, 2021 - Elsevier
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …

Prognostic Impact of Corticosteroids on Efficacy of Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma

P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee… - …, 2021 - scholar.rochesterregional.org
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …

[HTML][HTML] Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee, SP Iyer… - Blood, 2021 - ncbi.nlm.nih.gov
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee, SP Iyer… - Blood, 2021 - ashpublications.org
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.

P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee, SP Iyer… - Blood, 2021 - europepmc.org
Corticosteroids are commonly used for the management of severe toxicities associated with
chimeric antigen receptor (CAR) T-cell therapy. However, it remains unclear whether their …